Actively Recruiting
When to Perform Cardiac Magnetic Resonance in Patients Referred for Premature Ventricular Complexes by Their Cardiologists
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-02-13
200
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Premature ventricular complexes (PVC) are common, affecting about 20% of people. They may appear unexpectedly on an electrocardiogram (ECG) or cause symptoms like palpitations, chest pain, or fainting. Initial tests such as Holter ECG monitoring, echocardiography, and exercise stress tests help exclude structural heart disease, but sometimes subtle heart abnormalities may be missed. Cardiac magnetic resonance (CMR) imaging is the best way to assess heart function and detect issues like swelling, fatty replacement, or scarring in the heart muscle, but its exact role in patients with PVC is still unclear. This observational study aims to find out when CMR should be used to provide additional diagnosis or prognostic information beyond initial tests for patients referred for PVC by their cardiologists. The study will observe patients who have already had ECG, Holter ECG, and CMR scans, focusing on identifying myocardial abnormalities using CMR. Participants will be adults with PVC who have undergone these heart assessments. Researchers will review CMR results to count detected heart abnormalities and analyze factors that predict these findings. The main measurement is the number of myocardial abnormalities identified by CMR on the first day. This study will help clarify the value of CMR in evaluating PVC and guide future heart care for these patients.
CONDITIONS
Brief Title
WHEN DO WE HAVE to PERFORM CARDIAC MAGNETIC RESONANCE in PATIENTS REFERRED for PREMATURE VENTRICULAR COMPLEXES by THEIR CARDIOLOGISTS
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with premature ventricular complexes (PVC) who have undergone ECG, Holter ECG, and cardiac magnetic resonance (CMR) imaging
You will not qualify if you...
- Patients who oppose the use of their personal data for research
- Patients unable to express opposition
- Patients deprived of liberty
- Patients with language difficulties in speaking or writing French
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 1 day
Participants undergo cardiac magnetic resonance imaging and related diagnostic assessments to identify myocardial abnormalities.
1 visit (in-person)
Duration - Up to 18 months
Participants are observed over time to monitor cardiac health and outcomes after diagnostic evaluation.
Trial Site Locations
Total: 1 location
1
Centre Hospital-Universitaire d'Amiens
Salouël, France, 80480
Actively Recruiting
Research Team
E
Emmanuelle VERMES, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here